GNS Healthcare

The collaboration uses virtual patients built with multiomic and clinical data to identify aggressive disease subtypes and discover new drug targets.

Investigators plan to tap into large genomic and other datasets with an in silico patient to simulate drug responses, uncover treatment targets, and assess therapies.

GNS Healthcare will apply its AI and simulation technology to data from the CoMMpass study in search of insights on disease progression and drug response.